We propose that UM171 exerts its effect through two independent pathways (i) HSC expansion markers via PIM1, which could increase leukemia stemness; (ii) growth suppression via as yet to be defined target that controls the tumor suppressor genes KLF2 and P21CIP1. This evidence concerns the gene CDKN1A and leukemia.